OMR Global, Market Research company

The US synthetic biology market is anticipated to grow at a CAGR of 31.8% during the forecast period. The synthetic biology market in the US is driven by extensive funding by government officials, increasing number of companies in the field of synthetic biology and technological advancements in the life science sector. Since the beginning of synthetic biology, the US has been conducting synthetic biology research for more than 15 years and has made progress. The US is the largest investor in public research funding and it continues to increase its investment in order to maintain its position at the global level.  To Request a Sample of our Report on United States Synthetic Biology Market :   https://www.omrglobal.com/request-sample/us-synthetic-biology-market Large-scale integrated programs are being funded by the government agencies such as the NSF and DARPA to innovate solutions for sustainable development. Furthermore, the increasing roadmap studies in synthetic bi...

The UK synthetic biology market is anticipated to grow at the CAGR of around 30.0% during the forecast period. Major factors that are expected to augment the market are funding by the government organization research carried out by various universities, and funding provided to the fellowship. As the market is yet to commercialize most of the market of synthetic biology is based on the research and development activities carried in the nation. Some of the major research institutes working toward synthetic biology in the country are University of Cambridge, University of Edinburgh, University of Nottingham, The UK’s national industrial centre for synthetic biology and so on.  To Request a Sample of our Report on UK Synthetic Biology Market :   https://www.omrglobal.com/request-sample/uk-synthetic-biology-market The UK synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling p...

The UK infusion therapy devices market is anticipated to grow at a CAGR of 5.8% during the forecast period owing to the increasing prevalence of chronic diseases, such as cancer and diabetes and emerging demand for home infusion therapy in the country. As per the International Agency for Research on Cancer (IARC), in 2018, the number of new cancer incidences reported in the country was 446,942. Prostate cancer and breast cancer had the largest number of new cancer incidences in UK. The number of new incidences of prostate cancer and breast cancer was 56,401 and 55,439, which is 12.6% and 12.4% of all new cancer incidences reported in 2018. This will likely result in the emerging demand for chemotherapy for cancer treatment in the country, which increases the need for infusion therapy.  To Request a Sample of our Report on UK Infusion Therapy Devices Market :   https://www.omrglobal.com/request-sample/uk-infusion-therapy-devices-market The UK infusion therapy devices m...

The North American synthetic biology market is anticipated to grow at a CAGR of 31.0% during the forecast period. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies. Further, the growing support from the government, private institutions, and increasing R&D investments in the development of the drugs are other major factors that are expected to drive the North American synthetic biology market growth during the forecast period.   To Request a Sample of our Report on North American Synthetic Biology Market :   https://www.omrglobal.com/request-sample/north-american-synthetic-biology-market Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a p...

The North American infusion therapy devices market is projected to witness a considerable growth rate by exhibiting a significant CAGR of 5.0% during the forecast period. The market growth is driven by the increasing aging population and the rising incidence of chronic diseases such as diabetes, cancer, and others. Moreover, the rising number of surgeries performed in hospitals and ambulatory care settings, rising demand for diabetes management devices are contributing to the market growth in North America. The prevalence of diabetes is increasing in the region which is a major factor making a shift for the need for the infusion pump. According to IDF, the prevalence of diabetes is around 13.3% of the total adult population in the region which is expected to increase up to 14.2% by 2030 and 15% by 2045. In numbers, it is around 47.6 million in 2019 which is expected to augment 56 million by 2030. To Request a Sample of our Report on North American Infusion Therapy Devices Market :...

The LAMEA synthetic biology market is anticipated to grow at a CAGR of more than 30.0% during the forecast period. In Brazil, a university called the University of Sao Paulo (USP) h USP SynBio has been established that is promoting R&D in that region. The Synthetic Biology Center is being set-up with the objective to bring researchers from all disciplines of biomechanical engineering, chemistry, biosciences, engineering and statistics for synthetic biology. One of the fastest applications of synthetic biology in Brazil is being reported in the field of renewable energy from biofuels and biomass production.   To Request a Sample of our Report on Latin America and Middle East Africa (LAMEA) Synthetic Biology Market :   https://www.omrglobal.com/request-sample/lamea-synthetic-biology-market Additionally, the market is driven by the need for biofuel production with core R&D financing programs run by FAPESP. In July 2015, the Sao Paulo Research Foundation (FAP...